Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis
- PMID: 14579280
- DOI: 10.1002/eji.200324270
Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis
Abstract
Interactions between CD8+ T cells and endothelial cells are important in both protective and pathologic immune responses. Endothelial cells regulate the recruitment of CD8+ T cells into tissues, and the activation of CD8+ T cells by antigen presentation and costimulatory signals. PD-L1 and PD-L2 are recently described B7-family molecules which bind to PD-1 on activated lymphocytes and down-regulate T cell activation. We found that PD-L1 is expressed on interferon-gamma stimulated cultured human and mouse endothelial cells, while PD-L2 was found on stimulated human but not mouse endothelial cells. Expression was further up-regulated by TNF-alpha. Antibody blockade of endothelial cell PD-L1 and PD-L2 enhanced endothelial cell costimulation of PHA-activated human CD8+ T cells. Antibody blockade of mouse endothelial cell PD-L1 enhanced both IFN-gamma secretion and cytolytic activity of CD8+ T cells in response to endothelial cell antigen presentation. These results show that IFN-gamma activated endothelial cells can inhibit T cell activation via expression of the immunoinhibitory PD-L1 and PD-L2 molecules. Endothelial expression of PD-ligands would allow activation and extravasation of T cells without excessive vessel damage. Our findings highlight a potentially important pathway by which endothelial cells down-regulate CD8+ T cell-mediated immune responses.
Similar articles
-
PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.Nephrol Dial Transplant. 2007 Jun;22(6):1527-36. doi: 10.1093/ndt/gfl818. Epub 2007 Mar 5. Nephrol Dial Transplant. 2007. PMID: 17339272
-
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527
-
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10691-6. doi: 10.1073/pnas.0307252101. Epub 2004 Jul 12. Proc Natl Acad Sci U S A. 2004. PMID: 15249675 Free PMC article.
-
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.Transpl Int. 2008 Nov;21(11):1015-28. doi: 10.1111/j.1432-2277.2008.00726.x. Epub 2008 Jul 25. Transpl Int. 2008. PMID: 18662368 Review.
-
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.Nat Immunol. 2007 Mar;8(3):239-45. doi: 10.1038/ni1443. Nat Immunol. 2007. PMID: 17304234 Review.
Cited by
-
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.J Immunol. 2012 May 15;188(10):4876-84. doi: 10.4049/jimmunol.1200389. Epub 2012 Apr 9. J Immunol. 2012. PMID: 22491251 Free PMC article.
-
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation.Nat Rev Cancer. 2022 Nov;22(11):640-656. doi: 10.1038/s41568-022-00503-z. Epub 2022 Sep 15. Nat Rev Cancer. 2022. PMID: 36109621 Review.
-
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways.Cell Commun Signal. 2024 Aug 19;22(1):405. doi: 10.1186/s12964-024-01776-7. Cell Commun Signal. 2024. PMID: 39160622 Free PMC article. Review.
-
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.J Immunol. 2007 Oct 15;179(8):5204-10. doi: 10.4049/jimmunol.179.8.5204. J Immunol. 2007. PMID: 17911605 Free PMC article.
-
Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8+IFN-γ+ T cells in atherosclerosis.Inflamm Res. 2023 Apr;72(4):783-796. doi: 10.1007/s00011-023-01703-5. Epub 2023 Mar 3. Inflamm Res. 2023. PMID: 36867228
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials